Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Yuan Bai

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 29, 2023
Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort studyYu-Wei Liu, Jui-Ying Lee, Yao-Kuang Wang, et al.
Annals of Hematology|January 20, 2018
Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cellsWen-Jyi Lo, Chiao-Lin Lin, Yu-Chien Chang, et al.
Oncology Reports|February 12, 2005
Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphomaMuh-Hwa Yang, Chueh-Chuan Yen, Shu-Chung Chiang, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
The Oncologist|June 29, 2026
Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsApostolia Maria Tsimberidou, Darren Sigal, Anna Varghese, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 20, 2015
Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpuraTzeon-Jye Chiou, Yi-Fang Chang, Ming-Chung Wang, et al.
Hepatology (Baltimore, Md.)|September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 studyMitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Phase 1b/2 Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction AdenocarcinomaKeun-Wook Lee, Li-Yuan Bai, Minkyu Jung, et al.
Environmental Toxicology|May 8, 2019
Ursolic acid induces apoptosis and autophagy in oral cancer cellsCheng-Wen Lin, Hsien-Kuo Chin, Shou-Lun Lee, et al.
Anticancer Research|April 3, 2020
Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiationChen-Yuan Lin, Hsin-Yuan Fang, Ming-Yu Lein, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 29, 2023
Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort studyYu-Wei Liu, Jui-Ying Lee, Yao-Kuang Wang, et al.
Annals of Hematology|January 20, 2018
Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cellsWen-Jyi Lo, Chiao-Lin Lin, Yu-Chien Chang, et al.
Oncology Reports|February 12, 2005
Prognostic significance of clonal diversity of immunoglobulin gene rearrangements in patients with diffuse large B-cell lymphomaMuh-Hwa Yang, Chueh-Chuan Yen, Shu-Chung Chiang, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
The Oncologist|June 29, 2026
Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsApostolia Maria Tsimberidou, Darren Sigal, Anna Varghese, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 20, 2015
Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpuraTzeon-Jye Chiou, Yi-Fang Chang, Ming-Chung Wang, et al.
Hepatology (Baltimore, Md.)|September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 studyMitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Phase 1b/2 Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction AdenocarcinomaKeun-Wook Lee, Li-Yuan Bai, Minkyu Jung, et al.
Environmental Toxicology|May 8, 2019
Ursolic acid induces apoptosis and autophagy in oral cancer cellsCheng-Wen Lin, Hsien-Kuo Chin, Shou-Lun Lee, et al.
Anticancer Research|April 3, 2020
Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiationChen-Yuan Lin, Hsin-Yuan Fang, Ming-Yu Lein, et al.
Pageof 16